CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 NGS Genetic DNA Test
Introduction
The CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 NGS Genetic DNA Test is a cutting-edge diagnostic tool that employs Next Generation Sequencing (NGS) technology to identify genetic mutations associated with epilepsy. This test is particularly significant for individuals with a family history of nocturnal frontal lobe seizures, providing vital information that can guide treatment and management strategies.
What the Test Measures
This genetic test specifically detects mutations in the CHRNA2 gene, which plays a crucial role in neuronal signaling. By analyzing the genetic material from your blood or extracted DNA, the test can reveal whether you carry any mutations that increase the risk of developing epilepsy or related neurological disorders.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Patients experiencing nocturnal frontal lobe seizures.
- Individuals with a family history of epilepsy, particularly those with known cases of CHRNA2 gene mutations.
- Patients referred by neurologists for genetic counseling due to unexplained seizure disorders.
Benefits of Taking the Test
Taking the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 NGS Genetic DNA Test can provide numerous benefits, including:
- Identification of genetic predispositions to epilepsy, aiding in early diagnosis and intervention.
- Informed family planning and risk assessment for relatives.
- Guidance for personalized treatment options based on genetic findings.
- Peace of mind for patients and families regarding their health risks.
Understanding Your Results
Results from the test will indicate whether any mutations in the CHRNA2 gene were detected. A genetic counselor or neurologist will help interpret these results, discussing their implications for you and your family. Understanding your genetic profile can empower you to make informed health decisions.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across major cities in Kenya and offer a convenient home sample collection service. To book the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
Pre-Test Instructions
Before taking the test, it is essential to have a clinical history review with a neurologist and undergo a genetic counseling session to draw a pedigree chart of family members affected by CHRNA2 Gene Epilepsy. This step ensures that all relevant family health history is considered.
